Related Experiment Video
Updated: May 25, 2026

In Vitro Polymerization of F-actin on Early Endosomes
Published on: August 28, 2017
Pannexin1 drives multicellular aggregate compaction via a signaling cascade that remodels the actin cytoskeleton
Brian A Bao1, Charles P Lai, Christian C Naus
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Center for Biomedical Engineering, Brown University, Providence, Rhode Island 02912, USA.
Abstract:
Pannexin 1 (Panx1) is a novel gap junction protein shown to have tumor-suppressive properties. To model its in vivo role in the intratumor biomechanical environment, we investigated whether Panx1 channels modulate the dynamic assembly of multicellular C6 glioma aggregates. Treatment with carbenoxolone and probenecid, which directly and specifically block Panx1 channels, respectively, showed that Panx1 is involved in accelerating aggregate assembly. Experiments further showed that exogenous ATP can reverse the inhibitive effects of carbenoxolone and that aggregate compaction is sensitive to the purinergic antagonist suramin. With a close examination of the F-actin microfilament network, these findings show that Panx1 channels act as conduits for ATP release that stimulate the P(2)X(7) purinergic receptor pathway, in turn up-regulating actomyosin function. Using a unique three-dimensional scaffold-free method to quantify multicellular interactions, this study shows that Panx1 is intimately involved in regulating intercellular biomechanical interactions pivotal in the progression of cancer.
Insights
Pannexin 1 (Panx1) channels release ATP, activating purinergic signaling and actomyosin function to promote cancer cell aggregate assembly. This study reveals Panx1
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- Pannexin 1 (Panx1) is a gap junction protein with identified tumor-suppressive roles.
- The role of Panx1 in the tumor's biomechanical microenvironment remains unclear.
Purpose of the Study:
- To investigate the role of Panx1 channels in modulating the dynamic assembly of multicellular C6 glioma aggregates.
- To elucidate the underlying molecular mechanisms, including purinergic signaling and cytoskeletal regulation.
Main Methods:
- Utilized pharmacological inhibitors (carbenoxolone, probenecid) to block Panx1 channels.
- Investigated the effects of exogenous ATP and purinergic antagonists (suramin).
- Examined the F-actin microfilament network and employed a 3D scaffold-free method to quantify multicellular interactions.
Main Results:
- Panx1 channel blockade inhibited glioma aggregate assembly.
- Exogenous ATP reversed the inhibitory effects of Panx1 blockers.
- Aggregate compaction was sensitive to purinergic antagonism.
- Panx1 channels facilitate ATP release, activating the P(2)X(7) receptor and up-regulating actomyosin function.
Conclusions:
- Panx1 channels are crucial regulators of intercellular biomechanical interactions in C6 glioma aggregates.
- Panx1-mediated ATP release and purinergic signaling are pivotal in controlling aggregate assembly and cancer progression.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
The Role of Actin and Myosin in Non-muscle Cells
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Formation of Higher-order Actin Filaments
The high-order actin networks...
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...

